Decitabine

Steven D. Gore, Carole Jones, Peter Kirkpatrick

Research output: Contribution to journalArticlepeer-review

Abstract

Decitabine (Dacogen; MGI Pharma), a nucleoside analogue that inhibits DNA methylation, was approved by the US FDA for the treatment of myelodysplastic syndromes in May 2006.

Original languageEnglish (US)
Pages (from-to)891-892
Number of pages2
JournalNature Reviews Drug Discovery
Volume5
Issue number11
DOIs
StatePublished - Nov 1 2006

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Fingerprint Dive into the research topics of 'Decitabine'. Together they form a unique fingerprint.

Cite this